These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 10532543

  • 1. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA, Ringers J, Kuhn EM, Boon L, Lorré K, van den Hout Y, Bruijn JA, de Boer M, Jonker M, de Waele P.
    Transplantation; 1999 Oct 15; 68(7):1010-8. PubMed ID: 10532543
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
    Kirk AD, Tadaki DK, Celniker A, Batty DS, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM.
    Transplantation; 2001 Aug 15; 72(3):377-84. PubMed ID: 11502964
    [Abstract] [Full Text] [Related]

  • 4. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE, Bayer AL, Chavin KD, Blue ML, Baliga P.
    Transplantation; 1998 Jul 15; 66(1):14-20. PubMed ID: 9679816
    [Abstract] [Full Text] [Related]

  • 5. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP, Ossevoort M, Sick EA, Haanstra K, Jonker M.
    Transpl Immunol; 2003 Jul 15; 11(2):215-22. PubMed ID: 12799206
    [Abstract] [Full Text] [Related]

  • 6. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP, Xu H, Tadaki DK, Celniker A, Burkly LC, Berning JD, Cruzata F, Elster EA, Gray G, Kampen RL, Swanson SJ, Harlan DM, Kirk AD.
    Transplantation; 2002 Nov 27; 74(10):1365-9. PubMed ID: 12451232
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice.
    Kano M, Bashuda H, Yagita H, Okumura K, Morishita Y.
    Transplantation; 1998 Mar 27; 65(6):837-43. PubMed ID: 9539097
    [Abstract] [Full Text] [Related]

  • 9. Blocking of costimulation prevents kidney graft rejection in rhesus monkeys.
    Ossevoort MA, Ringers J, Boon L, Lorré K, van den Hout Y, Kuhn EM, de Boer M, Jonker M, de Waele P.
    Transplant Proc; 1998 Aug 27; 30(5):2165-6. PubMed ID: 9723429
    [No Abstract] [Full Text] [Related]

  • 10. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, Yagita H, Okumura K, Miyasaka M.
    Transplantation; 2000 May 27; 69(10):2144-8. PubMed ID: 10852614
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
    Lenschow DJ, Zeng Y, Hathcock KS, Zuckerman LA, Freeman G, Thistlethwaite JR, Gray GS, Hodes RJ, Bluestone JA.
    Transplantation; 1995 Nov 27; 60(10):1171-8. PubMed ID: 7482727
    [Abstract] [Full Text] [Related]

  • 12. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.
    Denton MD, Geehan CS, Alexander SI, Sayegh MH, Briscoe DM.
    J Exp Med; 1999 Aug 16; 190(4):555-66. PubMed ID: 10449526
    [Abstract] [Full Text] [Related]

  • 13. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
    Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13967-72. PubMed ID: 8943044
    [Abstract] [Full Text] [Related]

  • 14. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A, Marín L, Torío A, Muro M, García-Alonso AM, Moya-Quiles MR, Sánchez-Bueno F, Parrilla P, Alvarez-López MR.
    Hum Immunol; 2000 Jul 26; 61(7):658-69. PubMed ID: 10880736
    [Abstract] [Full Text] [Related]

  • 15. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC, Kang I, Barthold SW, Bockenstedt LK.
    Infect Immun; 1998 Jan 26; 66(1):266-71. PubMed ID: 9423867
    [Abstract] [Full Text] [Related]

  • 16. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K, Van Gool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P.
    Immunology; 1999 Nov 26; 98(3):413-21. PubMed ID: 10583602
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F, Hori J, Kamiya K, Kaji Y, Oshika T, Amano S, Yamagami S, Tsuru T, Tanaka S, Matsuda H, Yagita H, Okumura K.
    Exp Eye Res; 2002 Jan 26; 74(1):131-9. PubMed ID: 11878826
    [Abstract] [Full Text] [Related]

  • 18. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ, Nguyen P, Peach R, Gause WC, Via CS.
    J Immunol; 2002 Apr 15; 168(8):3786-92. PubMed ID: 11937530
    [Abstract] [Full Text] [Related]

  • 19. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.
    Yuan X, Salama AD, Dong V, Schmitt I, Najafian N, Chandraker A, Akiba H, Yagita H, Sayegh MH.
    J Immunol; 2003 Mar 15; 170(6):2949-55. PubMed ID: 12626546
    [Abstract] [Full Text] [Related]

  • 20. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z, Joost van Neerven RJ, Kasran A, de Boer M, Ceuppens JL.
    Int Immunol; 1996 Jan 15; 8(1):37-44. PubMed ID: 8671587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.